Bexacat tablet for cats 15 mg 30 Tab
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Bexacat® (bexagliflozin tablets) is an oral SGLT2 inhibitor to manage feline diabetes mellitus. It lowers blood glucose by increasing urinary excretion of glucose through inhibition of sodium-glucose cotransporter 2 (SGLT2), and results in effective glycemic control.
Product Details
| Active Ingredients | Bexagliflozin |
| Species | Cat |
| Therapeutic Use | Antidiabetic |
| Form | Tablet |
| Route of Administration | Oral |
| Strength / Concentration | 15 mg |
| Pack Size | 1 x 30-tablet bottle |
| DIN | 02562936 |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Elanco |
|---|---|
| DIN | 02562936 |
| Active Ingredient | Bexagliflozin |
| Strength | 15 mg |
| Pack Size | 30 Tab |
Storage & Shipping
| Shipping Weight | 0.03 kg |
|---|---|
| Storage Conditions | Ambient |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.